Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
G. O. Gallo-Oller, G. Pons, J. Sansa-Girona…·J. Roma
This study shows TRIB3 silencing reduces Akt pathway activity and PAX3-FOXO1 levels in high-risk rhabdomyosarcoma, leading to decreased tumor growth and improved survival.
G. Pons, G. Gallo-Oller, N. Navarro…·J. Roma
The paper identifies druggable collateral dependencies in cancer genomic amplifications using CRISPR/Cas9 screens and integrates gene dependency with druggability and subcellular location data.
C. Jimenez, R. Antonelli, M. Nadal-Ribelles…·M. F. Segura
This study shows that disrupting the BAF chromatin remodeller in neuroblastoma cells reduces metastasis by repressing an invasiveness-related epigenomic program.